Fig. 1: All-cause and treatment-related AEs. | British Journal of Cancer

Fig. 1: All-cause and treatment-related AEs.

From: Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours

Fig. 1

a All-cause AEs (all grades) occurring in ≥15% of patients and all-cause grade ≥3 AEs occurring in ≥2 patients, and b treatment-related AEs (investigator-assessed; all grades) occurring in ≥15% of patients and treatment-related grade ≥3 AEs occurring in ≥1 patient.

Back to article page